These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 8341679

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of interferon-gamma in interleukin 12-induced pathology in mice.
    Car BD, Eng VM, Schnyder B, LeHir M, Shakhov AN, Woerly G, Huang S, Aguet M, Anderson TD, Ryffel B.
    Am J Pathol; 1995 Dec; 147(6):1693-707. PubMed ID: 7495294
    [Abstract] [Full Text] [Related]

  • 25. Tumor necrosis factor-alpha induces increased hydrogen peroxide production and Fc receptor expression, but not increased Ia antigen expression by peritoneal macrophages.
    Hoffman M, Weinberg JB.
    J Leukoc Biol; 1987 Dec; 42(6):704-7. PubMed ID: 3316463
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric oxide.
    Frisch M, Gradehandt G, Mühlradt PF.
    Eur J Immunol; 1996 May; 26(5):1050-7. PubMed ID: 8647166
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD, Erickson KL.
    Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H, Stewart CA, Fast DJ, Leu RW.
    J Immunol; 1992 Sep 15; 149(6):2137-46. PubMed ID: 1517576
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant.
    Punjabi CJ, Laskin JD, Pendino KJ, Goller NL, Durham SK, Laskin DL.
    Am J Respir Cell Mol Biol; 1994 Aug 15; 11(2):165-72. PubMed ID: 7519435
    [Abstract] [Full Text] [Related]

  • 37. Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity.
    Frendl G, Beller DI.
    J Immunol; 1990 May 01; 144(9):3392-9. PubMed ID: 2158509
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Regulation of nitric oxide synthesis in wounds by IFN-gamma depends on TNF-alpha.
    Schäffer M, Bongartz M, Hoffmann W, Viebahn R.
    J Invest Surg; 2006 May 01; 19(6):371-9. PubMed ID: 17101606
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.